🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Studies evaluating the effects of itraconazole or rifampicin on the pharmac...
Status
Completed
Location
Yali Liu
Start Date
2024-03-12
Trial ID
NCT06255951
Treatments Being Tested
This study is to evaluate the efficacy and safety of TY-9591 in first-line ...
Status
Recruiting
Location
National Cancer Center/Cancer Hospitial,Chinese Academy of Medical Sciences and Peking Union Medical College
Start Date
2023-08-17
Trial ID
NCT05948813
Treatments Being Tested
To assess the pharmacokinetics of TY-9591 tablets and Osimertinib Mesylate ...
Status
Completed
Location
Hunan Provincial Tumor Hospital
Start Date
2021-04-30
Trial ID
NCT04798638
Treatments Being Tested
The primary objective of this study is to evaluate the safety and tolerabil...
Status
Completed
Location
Shanghai Chest Hospital
Start Date
2020-05-07
Trial ID
NCT04204473
Treatments Being Tested
To assess the efficacy and safety of TY-9591 versus Osimertinib in patients...
Status
Recruiting
Location
Hunan Provincial Tumor Hospital
Start Date
2022-06-08
Trial ID
NCT05382728
Treatments Being Tested
This study was a parallel, randomized, multicenter phase II clinical trial ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-02-20
Trial ID
NCT06672068
To evaluate the efficacy and safety of TY-9591 tablets in the treatment of ...
Status
Completed
Location
National Cancer Center/Cancer Hospitial,Chinese Academy of Medical Sciences and Peking Union Medical College
Start Date
2022-04-02
Trial ID
NCT05146219
Treatments Being Tested